Warren Averett Asset Management »

Aeglea Biotherapeutics shares owned by Warren Averett Asset Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Warren Averett Asset Management from 13F filings

Historical chart of Warren Averett Asset Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Warren Averett Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Warren Averett Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $435k 26k 16.76
2025-06-30 $291k 20k 14.97
2025-03-31 $314k 19k 16.14

More positions owned by Warren Averett Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Growth Etf (VUG)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf (VIG)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust Portfolio Intrmd (SPIB)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Etf (IWB)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
J P Morgan Exchange Traded F Income Etf (JPIE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Warren Averett Asset Management

Top funds holding Aeglea Biotherapeutics

FMR
Vanguard Group
Fairmount Funds Management
BlackRock
VR Adviser
Rtw Investments
Tang Capital Management
Capital Research and Management Company - Division 3
State Street Corporation
Driehaus Capital Management
Commodore Capital
Geode Capital Management
Wellington Management Company
Braidwell
Paradigm Biocapital Advisors

View all funds holding Aeglea Biotherapeutics